Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fond

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2022
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort studyG Fond, J Dubreucq, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2017
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohortG Fond, F Berna, M Andrianarisoa, et al.
L'Encephale|October 18, 2018
[The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice]F Schürhoff, G Fond, F Berna, et al.
Journal of Psychiatric Research|July 3, 2017
Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohortO Godin, M Leboyer, F Schürhoff, et al.
Schizophrenia Research|May 31, 2018
Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohortG Fond, L Boyer, F Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 4, 2018
Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohortJ Mallet, Y Le Strat, F Schürhoff, et al.
Psychiatry Research|September 25, 2018
Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 2, 2021
Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohortG Fond, P L Sunhary de Verville, R Richieri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 14, 2021
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohortP L Sunhary de Verville, D Etchecopar-Etchart, R Richieri, et al.
Psychopharmacology|December 4, 2015
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ datasetG Fond, L Boyer, M Favez, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2022
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort studyG Fond, J Dubreucq, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2017
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohortG Fond, F Berna, M Andrianarisoa, et al.
L'Encephale|October 18, 2018
[The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice]F Schürhoff, G Fond, F Berna, et al.
Journal of Psychiatric Research|July 3, 2017
Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohortO Godin, M Leboyer, F Schürhoff, et al.
Schizophrenia Research|May 31, 2018
Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohortG Fond, L Boyer, F Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 4, 2018
Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohortJ Mallet, Y Le Strat, F Schürhoff, et al.
Psychiatry Research|September 25, 2018
Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 2, 2021
Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohortG Fond, P L Sunhary de Verville, R Richieri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 14, 2021
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohortP L Sunhary de Verville, D Etchecopar-Etchart, R Richieri, et al.
Psychopharmacology|December 4, 2015
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ datasetG Fond, L Boyer, M Favez, et al.
Pageof 12